RedHill Biopharma (RDHL) News Today → The Gold Grab of the Century (From Colonial Metals) (Ad) Free RDHL Stock Alerts $0.45 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRedHill Biopharma (NASDAQ:RDHL) Coverage Initiated by Analysts at StockNews.comamericanbankingnews.com - May 4 at 2:39 AMRedHill Biopharma (NASDAQ:RDHL) Receives New Coverage from Analysts at StockNews.comamericanbankingnews.com - April 26 at 2:24 AMRedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Studyfinance.yahoo.com - April 24 at 11:40 AMRedHill Biopharma Full Year 2023 Earnings: EPS: US$4.00 (vs US$46.29 loss in FY 2022)finance.yahoo.com - April 10 at 10:40 AMRaleigh pharma weighs divesting commercial operationsbizjournals.com - April 9 at 1:31 PMRedHill Biopharma Ltd.: RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlightsfinanznachrichten.de - April 8 at 4:40 PMRedHill Biopharma Ltd. (2RH0.F)finance.yahoo.com - April 8 at 4:40 PMRedHill Biopharma Announces Full-Year 2023 Results and Operational Highlightsprnewswire.com - April 8 at 9:23 AMRedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Pricefinance.yahoo.com - April 2 at 10:24 AMRedHill Biopharma Receives New Patent For H. Pylori Treatment Taliciamarkets.businessinsider.com - March 11 at 12:39 PMRedHill Announces New USPTO Patent Covering Talicia® Through 2034finance.yahoo.com - March 11 at 7:36 AMRedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programsfinance.yahoo.com - March 5 at 9:11 AMRedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publicationfinance.yahoo.com - February 20 at 9:23 AMRedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publicationprnewswire.com - February 20 at 7:00 AMRedHill Biopharma Ltd. ADRbarrons.com - February 16 at 7:57 AMRedHill Biopharma Announces Closing of $8 Million Registered Direct Offeringfinance.yahoo.com - January 26 at 8:38 PMRedHill gains after new patent grant for Talicia for H. pylori treatment through 2042msn.com - January 25 at 9:37 AMRedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042finance.yahoo.com - January 25 at 9:37 AMRedHill Biopharma Announces $8 Million Registered Direct Offeringfinance.yahoo.com - January 25 at 9:37 AMWhy Redhill Biopharma Stock Is Moving Higherbenzinga.com - January 24 at 12:27 PMRedHill's Investigational COVID-19 Drugs Combined With Gilead's Show Effect Against Ebolamsn.com - December 20 at 6:33 PMRedHill Announces Results Of A New U.S. Army-funded In Vivo Ebola Virus Studymarkets.businessinsider.com - December 20 at 1:32 PMRedHill shares rally 20% on positive data for two antiviral drugsmsn.com - December 20 at 1:32 PMRedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebolafinance.yahoo.com - December 20 at 1:32 PMRedHill Biopharma regains compliance with Nasdaq listing rulemsn.com - December 12 at 10:12 AMRedHill Announces New, Non-Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase 2 Studyfinance.yahoo.com - December 4 at 7:36 AMRedhill Biopharma Stock (NASDAQ:RDHL), Short Interest Reportbenzinga.com - November 30 at 7:11 PMWhat's Going On With Redhill Biopharma Stock?msn.com - November 29 at 1:45 PMmarketbeat.com - November 29 at 11:01 AMmarketbeat.com - November 28 at 10:18 AMmarketbeat.com - November 28 at 9:43 AM5 Investors Betting Big on RedHill Biopharma (RDHL) Stockinvestorplace.com - November 27 at 4:18 PMWhy Is Gastrointestinal Disease Focused-RedHill Biopharma Stock Higher Over 100% Today?msn.com - November 27 at 1:40 PMRedHill's Talicia Granted 5-year Market Exclusivity By FDAmarkets.businessinsider.com - November 27 at 8:39 AMRedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034finance.yahoo.com - November 27 at 8:39 AMRedHill Biopharma Announces the Transfer of its Listing to The Nasdaq Capital Marketfinance.yahoo.com - November 22 at 1:59 AMThe Street Reports: Guide to Penny Stocks Look Now! CLNV, ARAV, RDHL, ATHX, EPAZbenzinga.com - October 19 at 10:45 AMIsrael-Based Penny Stock RedHill Biopharma Is Trading Higher Today - Here's Why?msn.com - October 3 at 1:29 PMRedHill and U.S. Army Announce Opaganib's Ebola Virus Disease Survival Benefit in U.S. Army-Funded In-Vivo Studyfinance.yahoo.com - October 3 at 8:28 AMRedHill Announces New USPTO Notice of Patent Allowance for Opaganib and EU Patent Grant for RHB-102 (BEKINDA®)finance.yahoo.com - September 5 at 8:06 AMRedHill Biopharma Provides H1/23 Financial Results and Operational Highlightsfinance.yahoo.com - August 17 at 7:52 AMRedHill's RHB-107 Included in U.S. Government-Supported COVID-19 Platform Trial and Cleared for Initiation by FDAfinance.yahoo.com - July 31 at 7:49 AMRedHill Biopharma Announces Closing of $3.8 Million Registered Direct Offering and Warrant Exercisefinance.yahoo.com - July 25 at 10:47 PMWhat's Going On With RedHill Biopharma Stock Todaybenzinga.com - July 21 at 5:22 PMRedHill Biopharma Announces Registered Direct Offering and Warrant Exercise for $3.8 Million Gross Proceedsfinance.yahoo.com - July 21 at 12:21 PMmarketbeat.com - July 21 at 9:35 AMRedHill Announces Additional U.S. Government Funding for Opaganib Nuclear Countermeasure Developmentfinance.yahoo.com - July 21 at 7:21 AMPhil and RedHill Biopharma Partner to Increase Access to Talicia®technews.tmcnet.com - July 6 at 9:43 AMRedHill Biopharma Ltd.: RedHill Biopharma Announces Q1/2023 Financial Results and Operational Highlightsfinanznachrichten.de - June 12 at 7:22 PMRedHill Biopharma Announces Q1/2023 Financial Results and Operational Highlightsfinance.yahoo.com - June 12 at 7:22 PM Get RedHill Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RDHL and its competitors with MarketBeat's FREE daily newsletter. Email Address FW: 234x Gain (Ad)This coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain. Click here. RDHL Media Mentions By Week RDHL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RDHL News Sentiment▼0.000.42▲Average Medical News Sentiment RDHL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RDHL Articles This Week▼11▲RDHL Articles Average Week Get RedHill Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RDHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MIRA Pharmaceuticals News Today Purple Biotech News Today ABVC BioPharma News Today Imunon News Today Kiora Pharmaceuticals News Today Akari Therapeutics News Today Elevai Labs News Today AgeX Therapeutics News Today Monopar Therapeutics News Today NanoViricides News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RDHL) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RedHill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
